Flushing, blushing, red cheeks, and flare-ups—these are just some of the things that people with rosacea have to cope with on a regular basis. Topical treatments generally address the inflammation and the lesions associated with rosacea, but now there is a new option specifically formulated to treat the redness and flushing. Galderma Laboratories Mirvaso® (brimonidine) topical gel, 0.33% for the topical treatment of the facial erythema (redness) of rosacea in adults 18 years of age or older just received the official nod from the FDA late last month. Applied once daily, Mirvaso reduces the redness of rosacea and will help keep your face clear up to 12 hours.
“The new FDA approved drug Mirvaso is an excellent addition to rosacea treatment. It is the first medication that will treat redness. The way it works is by constricting blood vessels. In the past, the only other way we could treat redness in rosacea patients was by using a laser, which is an expensive treatment,” says New York City dermatologist Debra Jaliman.
Rosacea is a chronic, inflammatory and vascular condition that affects the face. According to Galderma, “Mirvaso is a topical gel that may work by constricting the dilated facial blood vessels to reduce the redness of rosacea.”
The new drug joins two other Galderma prescription treatments for rosacea: Oracea® and MetroGel®1% Pump for treatment of the pimples and inflammatory lesions caused by rosacea.
For rosacea sufferers eagerly awaiting this new drug, Galderma expects Mirvaso to be available in pharmacies as of September 2013.
Dr. Jaliman also stresses that rosacea patients tend to have very sensitive skin and must always use broad-spectrum sunscreen that is chemical free. “I prefer physical sunscreens that contain zinc oxide or titanium dioxide. It is known that ultraviolet light is a trigger for rosacea. In addition, I give all my patients a food list with foods to avoid when they have rosacea. Spicy foods, citrus, caffeine, and wine are major culprits.
For more information about rosacea and its triggers, visit: rosacea.org.